← FDA DRUG APPROVALS

FDA ANDA · ANDA064106

MITOMYCIN

Sponsor: HOSPIRA

APPLICATION
ANDA064106
TYPE
ANDA
ORIGINAL APPROVAL
1995-11-29
LATEST ACTION
2001-07-30
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

MITOMYCINDiscontinued
MITOMYCIN 20MG/VIAL · INJECTABLE · INJECTION

Approval history

2001-07-30Manufacturing (CMC) · Supplement 11AP
2001-05-14Manufacturing (CMC) · Supplement 10AP
2000-10-11Labeling · Supplement 8AP
2000-08-08Manufacturing (CMC) · Supplement 6AP
2000-07-12Manufacturing (CMC) · Supplement 7AP
2000-05-15Manufacturing (CMC) · Supplement 5AP
2000-05-12Manufacturing (CMC) · Supplement 4AP
1999-06-18Manufacturing (CMC) · Supplement 2AP
1995-11-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →